vs
Encompass Health Corp（EHC）与Rivian Automotive, Inc.（RIVN）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是Rivian Automotive, Inc.的1.2倍（$1.5B vs $1.3B），Encompass Health Corp净利率更高（9.5% vs -63.1%，领先72.5%），Encompass Health Corp同比增速更快（9.9% vs -25.8%），Encompass Health Corp自由现金流更多（$116.7M vs $-1.1B），过去两年Encompass Health Corp的营收复合增速更高（8.3% vs 3.3%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
Rivian Automotive是2009年成立的美国电动汽车制造商及汽车科技企业，主打基于自研滑板平台打造的电动SUV、皮卡及EDV电动配送货车，旗下R1T皮卡于2021年末正式开启交付，还计划于2023年底前在美国和加拿大布局专属充电网络，其平台可适配新车型也可对外授权使用。
EHC vs RIVN — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.3B |
| 净利润 | $146.1M | $-811.0M |
| 毛利率 | — | 9.3% |
| 营业利润率 | 16.7% | -64.8% |
| 净利率 | 9.5% | -63.1% |
| 营收同比 | 9.9% | -25.8% |
| 净利润同比 | 20.8% | -9.0% |
| 每股收益（稀释后） | $1.43 | $-0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.5B | $1.6B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.5B | $1.2B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.4B | $874.0M | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | $1.3B | $1.2B |
| Q4 25 | $146.1M | $-811.0M | ||
| Q3 25 | $126.5M | $-1.2B | ||
| Q2 25 | $142.1M | $-1.1B | ||
| Q1 25 | $151.5M | $-545.0M | ||
| Q4 24 | $120.9M | $-744.0M | ||
| Q3 24 | $108.2M | $-1.1B | ||
| Q2 24 | $114.1M | $-1.5B | ||
| Q1 24 | $112.5M | $-1.4B |
| Q4 25 | — | 9.3% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | -15.8% | ||
| Q1 25 | — | 16.6% | ||
| Q4 24 | — | 9.8% | ||
| Q3 24 | — | -44.9% | ||
| Q2 24 | — | -38.9% | ||
| Q1 24 | — | -43.8% |
| Q4 25 | 16.7% | -64.8% | ||
| Q3 25 | 14.9% | -63.1% | ||
| Q2 25 | 16.2% | -85.5% | ||
| Q1 25 | 16.4% | -52.8% | ||
| Q4 24 | 14.3% | -38.1% | ||
| Q3 24 | 13.6% | -133.8% | ||
| Q2 24 | 14.3% | -118.7% | ||
| Q1 24 | 13.6% | -123.3% |
| Q4 25 | 9.5% | -63.1% | ||
| Q3 25 | 8.6% | -75.3% | ||
| Q2 25 | 9.7% | -85.7% | ||
| Q1 25 | 10.4% | -44.0% | ||
| Q4 24 | 8.6% | -42.9% | ||
| Q3 24 | 8.0% | -125.9% | ||
| Q2 24 | 8.8% | -125.8% | ||
| Q1 24 | 8.5% | -120.1% |
| Q4 25 | $1.43 | $-0.66 | ||
| Q3 25 | $1.24 | $-0.96 | ||
| Q2 25 | $1.39 | $-0.97 | ||
| Q1 25 | $1.48 | $-0.48 | ||
| Q4 24 | $1.18 | $-0.67 | ||
| Q3 24 | $1.06 | $-1.08 | ||
| Q2 24 | $1.12 | $-1.46 | ||
| Q1 24 | $1.10 | $-1.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $6.1B |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $2.4B | $4.6B |
| 总资产 | $7.1B | $14.9B |
| 负债/权益比越低杠杆越低 | 1.00× | — |
8季度趋势，按日历期对齐
| Q4 25 | $72.2M | $6.1B | ||
| Q3 25 | $48.7M | $7.1B | ||
| Q2 25 | $99.1M | $7.5B | ||
| Q1 25 | $95.8M | $7.2B | ||
| Q4 24 | $85.4M | $7.7B | ||
| Q3 24 | $147.8M | $6.7B | ||
| Q2 24 | $154.4M | $7.9B | ||
| Q1 24 | $134.4M | $7.9B |
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | $5.5B | ||
| Q1 24 | $2.7B | $4.4B |
| Q4 25 | $2.4B | $4.6B | ||
| Q3 25 | $2.4B | $5.1B | ||
| Q2 25 | $2.3B | $6.1B | ||
| Q1 25 | $2.2B | $6.2B | ||
| Q4 24 | $2.1B | $6.6B | ||
| Q3 24 | $2.0B | $5.9B | ||
| Q2 24 | $1.8B | $6.8B | ||
| Q1 24 | $1.7B | $8.1B |
| Q4 25 | $7.1B | $14.9B | ||
| Q3 25 | $6.9B | $15.2B | ||
| Q2 25 | $6.8B | $15.6B | ||
| Q1 25 | $6.6B | $15.5B | ||
| Q4 24 | $6.5B | $15.4B | ||
| Q3 24 | $6.5B | $14.3B | ||
| Q2 24 | $6.4B | $15.4B | ||
| Q1 24 | $6.2B | $15.7B |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | 0.81× | ||
| Q1 24 | 1.54× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $-681.0M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | $-1.1B |
| 自由现金流率自由现金流/营收 | 7.6% | -89.0% |
| 资本支出强度资本支出/营收 | 14.8% | 36.0% |
| 现金转化率经营现金流/净利润 | 2.37× | — |
| 过去12个月自由现金流最近4个季度 | $439.2M | $-2.5B |
8季度趋势，按日历期对齐
| Q4 25 | $346.0M | $-681.0M | ||
| Q3 25 | $270.8M | $26.0M | ||
| Q2 25 | $270.2M | $64.0M | ||
| Q1 25 | $288.6M | $-188.0M | ||
| Q4 24 | $278.8M | $1.2B | ||
| Q3 24 | $267.8M | $-876.0M | ||
| Q2 24 | $217.4M | $-754.0M | ||
| Q1 24 | $238.8M | $-1.3B |
| Q4 25 | $116.7M | $-1.1B | ||
| Q3 25 | $83.7M | $-421.0M | ||
| Q2 25 | $113.3M | $-398.0M | ||
| Q1 25 | $125.5M | $-526.0M | ||
| Q4 24 | $80.1M | $856.0M | ||
| Q3 24 | $120.3M | $-1.2B | ||
| Q2 24 | $60.5M | $-1.0B | ||
| Q1 24 | $99.4M | $-1.5B |
| Q4 25 | 7.6% | -89.0% | ||
| Q3 25 | 5.7% | -27.0% | ||
| Q2 25 | 7.8% | -30.5% | ||
| Q1 25 | 8.6% | -42.4% | ||
| Q4 24 | 5.7% | 49.4% | ||
| Q3 24 | 8.9% | -131.9% | ||
| Q2 24 | 4.6% | -89.6% | ||
| Q1 24 | 7.6% | -126.5% |
| Q4 25 | 14.8% | 36.0% | ||
| Q3 25 | 12.7% | 28.7% | ||
| Q2 25 | 10.8% | 35.5% | ||
| Q1 25 | 11.2% | 27.3% | ||
| Q4 24 | 14.1% | 18.9% | ||
| Q3 24 | 10.9% | 31.7% | ||
| Q2 24 | 12.1% | 24.4% | ||
| Q1 24 | 10.6% | 21.1% |
| Q4 25 | 2.37× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.90× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 2.31× | — | ||
| Q3 24 | 2.48× | — | ||
| Q2 24 | 1.91× | — | ||
| Q1 24 | 2.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
RIVN
| Automotive Segment | $839.0M | 65% |
| Software And Services Segment | $447.0M | 35% |
| Regulatory Credits | $30.0M | 2% |
